Advances in Rheumatology (Nov 2021)

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis

  • Sueli Carneiro,
  • Penelope Esther Palominos,
  • Sônia Maria Alvarenga Anti,
  • Rodrigo Luppino Assad,
  • Rafaela Silva Guimarães Gonçalves,
  • Adriano Chiereghin,
  • Andre Marun Lyrio,
  • Antônio Carlos Ximenes,
  • Carla Gonçalves Saad,
  • Célio Roberto Gonçalves,
  • Charles Lubianca Kohem,
  • Cláudia Diniz Lopes Marques,
  • Cláudia Goldenstein Schainberg,
  • Eduardo de Souza Meirelles,
  • Gustavo Gomes Resende,
  • Lenise Brandao Pieruccetti,
  • Mauro Waldemar Keiserman,
  • Michel Alexandre Yazbek,
  • Percival Degrava Sampaio-Barros,
  • Ricardo da Cruz Lage,
  • Rubens Bonfiglioli,
  • Thauana Luíza Oliveira,
  • Valderílio Feijó Azevedo,
  • Washington Alves Bianchi,
  • Wanderley Marques Bernardo,
  • Ricardo dos Santos Simões,
  • Marcelo de Medeiros Pinheiro,
  • Cristiano Barbosa Campanholo

DOI
https://doi.org/10.1186/s42358-021-00219-y
Journal volume & issue
Vol. 61, no. 1
pp. 1 – 27

Abstract

Read online

Abstract Psoriatic arthritis (PsA) is a chronic and systemic immune disease characterized by inflammation of peripheral and/or axial joints and entheses in patients with psoriasis (PsO). Extra-articular and extracutaneous manifestations and numerous comorbidities can also be present. These recommendations replace the previous version published in May 2013. A systematic review of the literature retrieved 191 articles that were used to formulate 12 recommendations in response to 12 clinical questions, divided into 4 sections: diagnosis, non-pharmacological treatment, conventional drug therapy and biologic therapy. These guidelines provide evidence-based information on the clinical management for PsA patients. For each recommendation, the level of evidence (highest available), degree of strength (Oxford) and degree of expert agreement (interrater reliability) are reported.

Keywords